WisdomTree BioRevolution Fund (BATS:WDNA – Get Free Report) rose 0.9% during trading on Monday . The company traded as high as $19.05 and last traded at $19.03. Approximately 2,650 shares traded hands during mid-day trading, an increase of 226% from the average session volume of 814 shares. The stock had previously closed at $18.86.
WisdomTree BioRevolution Fund Trading Up 0.9%
The stock has a market capitalization of $2.85 million, a PE ratio of 17.03 and a beta of 1.01. The stock’s fifty day simple moving average is $17.99 and its 200-day simple moving average is $17.78.
Hedge Funds Weigh In On WisdomTree BioRevolution Fund
A hedge fund recently raised its stake in WisdomTree BioRevolution Fund stock. Jane Street Group LLC increased its holdings in WisdomTree BioRevolution Fund (BATS:WDNA – Free Report) by 45.9% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 16,864 shares of the company’s stock after acquiring an additional 5,306 shares during the period. Jane Street Group LLC owned about 11.24% of WisdomTree BioRevolution Fund worth $231,000 at the end of the most recent quarter.
About WisdomTree BioRevolution Fund
The WisdomTree BioRevolution Fund (WDNA) is an exchange-traded fund that is based on the WisdomTree BioRevolution index. The fund tracks a modified equally-weighted index of companies in developed markets that focus on the advancements in genetics and biotechnology. WDNA was launched on Jun 3, 2021 and is managed by WisdomTree.
Read More
- Five stocks we like better than WisdomTree BioRevolution Fund
- Buy CrowdStrike Before the Stock Split? Here’s the Case
- Investors Are Buying Into Sweetgreen Again—Should They?
- Burlington Is Winning Over Shoppers But Investors Need Patience
- USA Today’s Digital Revival Is Gaining Steam, But With Plenty of Risk
Receive News & Ratings for WisdomTree BioRevolution Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WisdomTree BioRevolution Fund and related companies with MarketBeat.com's FREE daily email newsletter.
